Advertisement

Reactions Weekly

, Volume 1734, Issue 1, pp 379–379 | Cite as

Nivolumab/pembrolizumab

Various toxicities: 5 case reports
Case report
  • 9 Downloads

Reference

  1. Zhao L, et al. Combination of PD-1 blockade and RetroNectin-activated cytokine-induced killer in preheavily treated non-small-cell lung cancer: A retrospective study. Immunotherapy 10: 1315-1323, No. 15, 23 Oct 2018. Available from: URL: http://doi.org/10.2217/imt-2018-0125 - China

Copyright information

© Springer Nature Switzerland AG 2019

Personalised recommendations